Wuhan Institute of Biological Products

About Wuhan Institute of Biological Products

Wuhan Institute of Biological Products (WIBP), a high-tech Chinese enterprise affiliated with CNBG (Sinopharm), integrates education, R&D, manufacturing, and marketing of biological products and holds over 60 production licenses. Its core marketed products include Rotasiro®-Reassortant Rotavirus Vaccine, Live, Oral, Hexavalent (Vero Cell), Enterovirus 71 Vaccine (Vero Cell), Inactivated and Tetanus Vaccine, Adsorbed and it also has a DTaP-IPV/Hib combination vaccine candidate.

  • Country/Region:
    China
  • Founded:
    1950
  • On CPHI since:
    2026
  • Certificates:
    1
  • Employees:
    1000 - 4999
Company types
Biopharmaceutical company
Primary activities
Biopharmaceutical
Contact info
Meet us at

CPHI Milan 2026

Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026

Products from Wuhan Institute of Biological Products (4)

  • Diphtheria,Tetanus,Pertussis (Acellular,Component),Poliomyelitis(Inactivated) Vaccine(Adsorbed) and Haemophilus Influenza Type B Conjugate Vaccine

    Product Diphtheria,Tetanus,Pertussis (Acellular,Component),Poliomyelitis(Inactivated) Vaccine(Adsorbed) and Haemophilus Influenza Type B Conjugate Vaccine

    This vaccine candidate consists of a vial of powder (Hib conjugate vaccine) and a prefilled syringe of suspension (DTaP-IPV).The powder is a white, porous solid containing Haemophilus influenzae type b polysaccharide conjugated to tetanus toxoid.The suspension is an adsorbed combined vaccine cont...
  • Enterovirus 71 Vaccine (Vero Cell), Inactivated

    Product Enterovirus 71 Vaccine (Vero Cell), Inactivated

    This EV71 vaccine is produced by inoculating Vero cells with the EV71 AHFY087VP5 strain, followed by cell culture, virus harvest, concentration, purification, inactivation, and aluminum hydroxide adsorption. It contains no antibiotics or preservatives, ensuring high purity and strong antigen activity. It i...
  • Rotasiro® -Reassortant Rotavirus Vaccine, Live, Oral, Hexavalent (Vero Cell)

    Product Rotasiro® -Reassortant Rotavirus Vaccine, Live, Oral, Hexavalent (Vero Cell)

    Launched in 2025,  Rotasiro® is the first hexavalent rotavirus vaccine in the world, covering serotypes G1, G2, G3, G4, G8, and G9. It offers six key advantages: exclusive coverage of serotypes G8 and G9, no risk of intussusception, a pure and palatable formulation, breakthrough homogeneous technology...
  • Tetanus Vaccine, Adsorbed

    Product Tetanus Vaccine, Adsorbed

    This vaccine is a purified tetanus toxoid adsorbed onto aluminum hydroxide. The toxoid is produced by culturing Clostridium tetani, followed by toxin refinement and detoxification. Manufactured with a 1,000L fully automated bioreactor, it ensures consistent quality, high toxoid activity, and superior ...

Wuhan Institute of Biological Products Resources (1)